Arthritis News and Research

Latest Arthritis News and Research

Alder’s initiation of ALD518/BMS-945429 Phase 2 trial triggers $3.5M milestone payment

Alder Biopharmaceuticals Inc. today announced it has received a $3.5 million milestone payment from Bristol-Myers Squibb for the initiation of a Phase 2 clinical trial of ALD518/BMS-945429, an investigational antibody therapeutic that blocks interleukin-6 (IL-6), in Crohn's disease.

28 Aug 2012

Adult surgery rescues overcorrected club foot deformity

Study findings support the use of supramalleolar osteotomy for patients with hindfoot valgus or subtalar joint deformity following an overcorrected clubfoot.

23 Aug 2012

UNH faculty member to study effectiveness of two distinct strength-training regimens on older adults

A University of New Hampshire faculty member has received a grant of more than $360,000 from the National Institutes of Health to study the effectiveness of two distinct strength-training regimens on older adults. The study will compare traditional resistance training exercises, in which participants build muscle strength by lifting heavy weights, to an innovative program that uses very light resistance coupled with blood flow restriction.

23 Aug 2012

Study quantifies discrepancies between physicians and patients with rheumatoid arthritis

For people suffering from rheumatoid arthritis, pain is the crucial factor in their personal perception of the condition. The doctors treating them, however, assess the severity of the disease based on the swelling of the joints. This discrepancy often leads to conflict between patients and their physicians, as a study by Daniel Aletaha and Paul Studenic from the University Department of Internal Medicine III at the MedUni Vienna has now revealed in more detail for the first time.

23 Aug 2012

Mosquitoes in the U.S. can be infected with Chikungunya virus from Asia

New research from SRI International finds that mosquitoes commonly found in the United States can be infected with a disease-causing virus from Asia. The research findings are from a recent study that modeled how mosquito-borne infections can become introduced.

23 Aug 2012

FDA warns consumers about potential health risks of two natural dietary supplements

The U.S. Food and Drug Administration today issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.

22 Aug 2012

Study on sea lamprey may indicate how potentially deleterious genes can be controlled

Research on a unique vertebrate called the sea lamprey shows that more than a thousand genes are shed during its early development.

22 Aug 2012

FDA extends action date for Pfizer’s tofacitinib NDA review

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has extended the action date by three months for the New Drug Application (NDA) for tofacitinib, an investigational oral treatment for adults with moderately to severely active rheumatoid arthritis (RA).

22 Aug 2012

CIRT to determine whether methotrexate can reduce heart attacks, strokes and CVD deaths

An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.

22 Aug 2012

GM-CSF depletion suppresses pain in people with arthritis-related conditions

The research relates to a family of molecules firstly discovered in Melbourne that applied to blood cell development. One of these, granulocyte macrophage colony-stimulating factor or GM-CSF, acts as a messenger between cells acting at a site of inflammation.

22 Aug 2012

Stem-cell therapy holds promise for postinjury arthritis prevention

A novel stem-cell treatment may hold the key to treating osteoarthritis triggered by joint injury, suggest results from an animal study.

21 Aug 2012

New silicon chips help identify patients with lupus

Researchers at the Stanford University School of Medicine and Intel Corp. have collaborated to synthesize and study a grid-like array of short pieces of a disease-associated protein on silicon chips normally used in computer microprocessors.

21 Aug 2012

Kineta receives regulatory clearance to commence ShK-186 Phase I trial in autoimmune disease

Seattle-based biotech company Kineta, Inc. announced today it has received regulatory clearance in the Netherlands to initiate a first-in-human trial of ShK-186, an autoimmune drug candidate that specifically inhibits the Kv1.3 potassium ion channel.

21 Aug 2012

Medivir initiates MIV-711 phase Ib trial in healthy volunteers

Medivir AB, the research-based pharmaceutical company focused on the development of high-value treatments for infectious diseases, is reporting today that a clinical phase Ib trial of the company's candidate drug (CD) MIV-711 has commenced.

21 Aug 2012

New attack on arthritis pain

A research team from the University of Melbourne is working on a new therapy that can potentially control the pain caused by diseases such as rheumatoid arthritis and osteoarthritis.

21 Aug 2012

Arthritis patients prioritize lifestyle intervention research

Most patients believe that research into joint pain should focus on self-management and lifestyle modifications, suggests a UK survey of older individuals with self-reported joint pain.

20 Aug 2012

Happtique introduces mRx solution for electronically prescribing medical apps

Happtique, a mobile health application store and total app management solution, today announced the commencement of its pilot program of mRx, Happtique's patent-pending solution that enables physicians and other health practitioners to electronically prescribe medical, health, and fitness apps to their patients.

20 Aug 2012

Arthritis News and Research

Latest Arthritis News and Research

Alder’s initiation of ALD518/BMS-945429 Phase 2 trial triggers $3.5M milestone payment

Adult surgery rescues overcorrected club foot deformity

UNH faculty member to study effectiveness of two distinct strength-training regimens on older adults

Study quantifies discrepancies between physicians and patients with rheumatoid arthritis

Mosquitoes in the U.S. can be infected with Chikungunya virus from Asia

FDA warns consumers about potential health risks of two natural dietary supplements

Study on sea lamprey may indicate how potentially deleterious genes can be controlled

FDA extends action date for Pfizer’s tofacitinib NDA review

CIRT to determine whether methotrexate can reduce heart attacks, strokes and CVD deaths

GM-CSF depletion suppresses pain in people with arthritis-related conditions

Stem-cell therapy holds promise for postinjury arthritis prevention

New silicon chips help identify patients with lupus

Kineta receives regulatory clearance to commence ShK-186 Phase I trial in autoimmune disease

Medivir initiates MIV-711 phase Ib trial in healthy volunteers

New attack on arthritis pain

Arthritis patients prioritize lifestyle intervention research

Happtique introduces mRx solution for electronically prescribing medical apps

'Yoga for Healthy Lower Backs' likely to be cost effective for both NHS and wider society

Preliminary results from Lexicon’s Phase 1 studies of LX2931 and LX7101 for RA

Tofacitinib shows promise in active ulcerative colitis

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Arthritis News and Research

Latest Arthritis News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in